MARATTO

article · Next Materials

Photocatalytic degradation of tetracycline and metronidazole in wastewater using Cu-chalcogenides/g-C3N4 composites

2026Open accessRedeemer's University

Abstract

The contamination of water resources by pharmaceutical compounds such as tetracycline (TC) and metronidazole (MZ) poses a significant environmental challenge. This study reports the synthesis, characterization, and application of g-C₃N₄-modified copper dichalcogenoimidodiphosphinate complexes as novel photocatalysts for the degradation of these pollutants under solar irradiation. Three composite materials (M408, M410, M409) were synthesized via solventless pyrolysis of g-C 3 N 4 with three Cu-chalcogenide complexes (Cu[(SePⁱPr 2 ) 2 N] 2 (C408), Cu[(SPⁱPr 2 )(SePⁱPr 2 )N] 2 (C410), and Cu[(SPⁱPr₂) 2 N] 2 (C409)). Among them, the M409 composite (Cu[(SPⁱPr 2 ) 2 N] 2 /g-C 3 N 4 ) demonstrated superior photocatalytic activity, achieving 88% and 85% degradation of TC and MZ (1 mg/L), respectively, within 180 min. Kinetic studies revealed that the degradation followed a pseudo-first-order Langmuir-Hinshelwood model, with the highest rate constants (k) observed at an initial concentration of 1 mg/L and a photocatalyst dose of 200 mg/L. The enhanced performance is attributed to the effective suppression of charge carrier recombination, as evidenced by photoluminescence spectroscopy. This work establishes these modified metal chalcogenide complexes as effective solar-active photocatalysts for wastewater remediation.

Research topics

  • Advanced Photocatalysis Techniques
  • Advanced oxidation water treatment
  • TiO2 Photocatalysis and Solar Cells

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.nxmate.2026.102425

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.